GEODON Drug Patent Profile
✉ Email this page to a colleague
When do Geodon patents expire, and when can generic versions of Geodon launch?
Geodon is a drug marketed by Viatris and Pfizer Inc and is included in three NDAs.
The generic ingredient in GEODON is ziprasidone mesylate. There are twenty-three drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ziprasidone mesylate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Geodon
A generic version of GEODON was approved as ziprasidone mesylate by GLAND PHARMA LTD on December 26th, 2019.
Summary for GEODON
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 81 |
Clinical Trials: | 48 |
Patent Applications: | 4,951 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GEODON |
What excipients (inactive ingredients) are in GEODON? | GEODON excipients list |
DailyMed Link: | GEODON at DailyMed |
![GEODON drug patent expirations Drug patent expirations by year for GEODON](/p/graph/s/t/GEODON-patent-expirations.png)
![Drug Prices for GEODON](/p/graph/drug-price/GEODON.png)
![Drug Sales Revenue Trends for GEODON](/p/graph/drug-sales-revenues/GEODON.png)
Recent Clinical Trials for GEODON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Astellas Pharma Global Development, Inc. | Phase 2 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
Duke University | Phase 1 |
Pharmacology for GEODON
Drug Class | Atypical Antipsychotic |
Anatomical Therapeutic Chemical (ATC) Classes for GEODON
Paragraph IV (Patent) Challenges for GEODON
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
GEODON | Capsules | ziprasidone hydrochloride | 20 mg, 40 mg, 60 mg and 80 mg | 020825 | 5 | 2005-02-07 |
US Patents and Regulatory Information for GEODON
GEODON is protected by zero US patents and one FDA Regulatory Exclusivity.
FDA Regulatory Exclusivity protecting GEODON
INFORMATION ADDED TO SECTION 8.4 OF THE LABELING TO DESCRIBE THE RESULTS FROM PEDIATRIC STUDIES
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-001 | Feb 5, 2001 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-004 | Feb 5, 2001 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-002 | Feb 5, 2001 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-003 | Feb 5, 2001 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Pfizer Inc | GEODON | ziprasidone hydrochloride | SUSPENSION;ORAL | 021483-001 | Mar 29, 2006 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for GEODON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-003 | Feb 5, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Viatris | GEODON | ziprasidone mesylate | POWDER;INTRAMUSCULAR | 020919-001 | Jun 21, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-004 | Feb 5, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer Inc | GEODON | ziprasidone hydrochloride | SUSPENSION;ORAL | 021483-001 | Mar 29, 2006 | ⤷ Try a Trial | ⤷ Try a Trial |
Viatris | GEODON | ziprasidone hydrochloride | CAPSULE;ORAL | 020825-001 | Feb 5, 2001 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for GEODON
See the table below for patents covering GEODON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
China | 1083061 | ⤷ Try a Trial | |
Hungary | 222451 | Aril-heterociklusos sók zárványkomplexei (INCLUSION COMPLEXES OF ARYL-HETEROCYCLIC SALTS) | ⤷ Try a Trial |
Norway | 324373 | ⤷ Try a Trial | |
Japan | 2003500449 | ⤷ Try a Trial | |
Hungary | T67023 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for GEODON
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0904273 | PA2003004 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002 |
0904273 | PA2003004,C0904273 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: ZIPRASIDONUM (5-(2-(4-(1,2-BENZIZOTIAZOL-3-IL)-1-PIPERAZINIL)ETIL)-6-CHLOR-1,3-DIHIDRO-2H-INDOL-2-ONAS); REGISTRATION NO/DATE: 02/7887/8 20021002 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |